Photon Fund

Bichen Pharmaceutical is a small-molecule tumor-targeted drug developer for the treatment of various malignant tumors and brain metastases.

Amplicore is a biotechnology company focused on developing injectable therapeutics for degenerative musculoskeletal disorders. The company aims to address unmet medical needs by promoting cartilage regeneration and suppressing enzymatic activities associated with conditions such as osteoarthritis, cartilage damage, degenerative disc disease, and acute meniscus tears. By providing innovative treatment options, Amplicore enables healthcare organizations to offer effective relief to patients suffering from joint pain.

Newomics Inc. is a biotechnology company based in Berkeley, California, established in 2011. It specializes in manufacturing advanced research equipment that utilizes proprietary silicon-microfluidic-chip technology for liquid chromatography-mass spectrometry (LC-MS). This innovative platform allows for highly sensitive, specific, and robust analyses of biomolecules from small quantities of biospecimens, such as blood and urine. Newomics focuses on developing multi-omics diagnostic assays for various conditions, including diabetes and Alzheimer's disease, enabling comprehensive proteomic, metabolomic, and lipidomic analyses. By integrating and miniaturizing mass spectrometry techniques, Newomics aims to enhance personalized healthcare through its cutting-edge technology.

Cardea Bio, Inc. is a biotechnology company based in San Diego, California, focused on developing and commercializing bioelectronics for research and diagnostics. Established in 2013, Cardea utilizes proprietary graphene-based digital biosensors to create advanced biosensor hardware, software, and molecular infrastructure, enabling precision healthcare through improved diagnostic capabilities. The company's product offerings include the AGILE R100, an innovative assay for drug discovery, and the AGILE R200, an automated high-throughput screening solution. Cardea's biosensors convert biomolecular interactions into digital data, allowing for real-time biological signal analysis and access to streaming multi-omics data. Their solutions cater to various applications in life sciences and healthcare, such as small molecule validation, antibody characterization, and biomolecular analysis.

Nelumbo Inc. is a materials innovation company based in Menlo Park, California, focused on developing advanced structural materials for the heating and cooling industry. Founded in 2015, the company specializes in manufacturing thin superomniphobic coatings, such as Ice-Nein and Omniphobe. These coatings enhance the performance of cooling coils in refrigeration and air conditioning systems by reducing frost buildup and improving energy efficiency, thereby minimizing equipment downtime and corrosion. Nelumbo's technology aims to unlock significant market opportunities by contributing to reductions in carbon emissions and energy consumption globally.

CASPR Biotech, founded in 2018 and located in San Francisco, California, specializes in the development of a CRISPR-based platform for diagnosing antimicrobial resistances (AMR) and infectious diseases. The company creates portable diagnostic kits that enable the detection of specific DNA and RNA sequences, as well as signature amino acid sequences associated with infectious diseases and genetic mutations. These kits aim to provide healthcare professionals with a simple, rapid, and cost-effective solution for molecular detection, enhancing the accuracy and efficiency of clinical diagnostics.

Valitor, Inc. is a biotechnology company founded in 2010 and based in Berkeley, California. The company specializes in developing advanced, protein-based drugs through innovative methods that enhance therapeutic proteins' pharmacokinetics, target specificity, and bioactivity. Valitor's technology platform is versatile, enabling improvements in the pharmacological properties of various existing and emerging protein drugs. The company has established development pipelines in dermatology, ophthalmology, and orthopedics, showcasing its capabilities in creating novel drug products tailored to specific medical needs.

Newomics Inc. is a biotechnology company based in Berkeley, California, established in 2011. It specializes in manufacturing advanced research equipment that utilizes proprietary silicon-microfluidic-chip technology for liquid chromatography-mass spectrometry (LC-MS). This innovative platform allows for highly sensitive, specific, and robust analyses of biomolecules from small quantities of biospecimens, such as blood and urine. Newomics focuses on developing multi-omics diagnostic assays for various conditions, including diabetes and Alzheimer's disease, enabling comprehensive proteomic, metabolomic, and lipidomic analyses. By integrating and miniaturizing mass spectrometry techniques, Newomics aims to enhance personalized healthcare through its cutting-edge technology.

Nelumbo Inc. is a materials innovation company based in Menlo Park, California, focused on developing advanced structural materials for the heating and cooling industry. Founded in 2015, the company specializes in manufacturing thin superomniphobic coatings, such as Ice-Nein and Omniphobe. These coatings enhance the performance of cooling coils in refrigeration and air conditioning systems by reducing frost buildup and improving energy efficiency, thereby minimizing equipment downtime and corrosion. Nelumbo's technology aims to unlock significant market opportunities by contributing to reductions in carbon emissions and energy consumption globally.

CARsgen Therapeutics, Ltd. is a clinical-stage immunotherapy company based in Shanghai, China, focused on developing chimeric antigen receptor T-cell (CAR-T) therapeutics for various cancers, including liver, lung, stomach, and brain cancers. The company specializes in CAR-T technology that enables T cells to target and destroy cancer cells by recognizing specific cell surface proteins. Notably, CARsgen’s therapies are designed to treat late-stage hepatocellular carcinoma (HCC) and lung squamous cell carcinoma. The company has also made significant advancements in clinical trials, having completed the world's first dose-ascending injection tests for HCC and exclusive tests for glioblastoma multiforme (GBM) in China. CARsgen collaborates with institutions such as the Shanghai Cancer Institute and Shanghai Renji Hospital, and is supported by prominent venture capital funding, positioning it to introduce innovative cancer treatments both in China and globally.

Hongliyu Cinema is a rural cinema operator based in China, specializing in the management and operation of local theaters. The company provides services related to cinema investment, operation management, and professional training, aiming to enhance the efficiency of theater operations and improve digital media services. Additionally, Hongliyu Cinema is involved in film and television production as well as advertising operation services, contributing to the development of the local cinema landscape.

FutureMove Automotive is a high-tech company based in the Jingyuan Art Center in Chaoyang District, Beijing, specializing in the Connected Vehicle industry. Founded in 2015, the company focuses on delivering service operation and information solutions, positioning itself as a pioneer in Digital and Mobility Services for the Internet era. With a team composed of professionals from leading IT companies, consulting firms, telecommunications, and the automotive sector, FutureMove Automotive has developed a comprehensive platform for smart vehicle technology. This platform enables connectivity for vehicles, offering data analytics and supporting various applications for next-generation vehicles. The company has experienced significant growth, currently employing over 150 staff members and continuing to expand its workforce as demand for its services increases.

Techtotop specializes in the development of satellite navigation and positioning microchips. The company has released four generations of these chips, which are utilized in various applications, including vehicle navigation, personal monitoring, smart wearables, and emerging Internet of Things (IoT) technologies. Their products also support functionalities in smart grids, radio and television broadcasting, time synchronization, and provide sub-meter precision for various positioning requirements. Notably, Techtotop's technology contributes to the establishment of the BeiDou Navigation Satellite System, enhancing the accuracy and reliability of location and time information across different sectors.

Yuedan is a personal services trading platform that connects freelance workers with job opportunities. It facilitates the buying and selling of skills and time, allowing individuals to monetize their expertise while helping users find nearby service providers. The platform is designed to empower freelancers to increase their income and offers a convenient way for people and businesses to access skilled services.